Originally Posted by gudugan

Good analysis. Option 1 isn't feasible. The data was just released from late 2020 phase 1 trial of ARCoV (domestic mRNA vaccine) and phase 3 is not released/keeps getting postponed. Basically, it's highly likely that ARCoV doesn't work for Omicron (if it works at all). https://www.thelancet.com/pdfs/journ...21)00280-9.pdf They can't get enough Moderna/BioNTech even if they wanted to (politics notwithstanding) and distribution will take a long time.